West Nile virus infection among health-fair participants, Wyoming 2003: Assessment of symptoms and risk factors

Vector-Borne and Zoonotic Diseases

Volumn 5, Issue 3, 2005, Pages 246-251

  Murphy, Tracy D ^a,b   Grandpre, Joe ^c   Novick, Sandra L ^d   Seys, Scott A ^c   Harris, Richard W ^d   Musgrave, Karl ^c  

^a Wyoming Department of Health   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Preventive Health and Safety Division   (United States)

^d Wyoming Public Health Laboratory   (United States)

Author keywords

Seroprevalence; Serosurvey; Symptoms; West Nile virus; Wyoming

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFECTION RISK; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; MUSCLE WEAKNESS; MYALGIA; PREVALENCE; PRIORITY JOURNAL; PUBLIC HOSPITAL; QUESTIONNAIRE; RASH; RISK FACTOR; SCHOOL CHILD; SYMPTOMATOLOGY; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CONFIDENCE INTERVALS; EXANTHEMA; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MUSCLE WEAKNESS; ODDS RATIO; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; WEST NILE FEVER; WEST NILE VIRUS; WYOMING;

WEST NILE VIRUS;

EID: 27144507015     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2005.5.246     Document Type: Article

References (9)

1. Emig, M, Apple, DJ. Severe West Nile disease in healthy adults. Clin Infect Dis 2004;38:289-292.
2. Gea-Banacloche, J, Johnson, RT, Bagic, A, et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 2004;140:545-553.
3. Johnson, AJ, Martin, DA, Karabatsos, N, et al. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 2000;38:1827-1831.
4. Martin, DA, Muth, DA, Brown, T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000;38:1823-1826.
5. McCarthy, TA, Hadler, JL, Julian, K, et al. West Nile virus serosurvey and assessment of personal prevention efforts in an area with intense epizootic activity: Connecticut, 2000. Ann N Y Acad Sci 2001;951:307-316.
6. Mostashari, F, Bunning, ML, Kitsutani, PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiologic survey. Lancet 2001;358:261-264.
7. Nash, D, Mostashari, F, Fine, A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-1814.
8. Roehrig, JT, Nash, D, Maldin, B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003;9:376-379.
9. Weiss, D, Carr, D, Kellachan, J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001; 7:654-658.